How Did Jim Cramer’s 12 Bold Predictions Play Out?

Page 11 of 12

2. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders: 115

Eli Lilly and Compnay (NYSE:LLY), known for its diabetes and weight-loss drugs, was mentioned at the time due to a strong earnings report driven by soaring demand for its GLP-1 medications. Cramer had a lot of positive things to say about it back then:

“Eli Lilly had a great day on a terrific quarter related to the sales of the GLP-1 weight loss and diabetes drugs. […]

How much do we know about the stock market fallout from Eli Lilly’s revolutionary weight loss drug, Zepbound? Yeah a lot less than we thought we did. […] We know the Market’s growing. Lilly put up amazing numbers today raising its full year revenue forecast by an astounding $2 billion. CEO David Ricks said that they’re doing their best to make enough of the drug but it’s hard to keep up. According to Ricks, the demand is very strong and each week hundreds of thousands of people fill scripts.”

Jim Cramer’s love for Eli Lilly and Company (NYSE:LLY) has been justified, with the stock being up 20.08% over the past 12 months.

Jim Cramer remains a fan and continues to own the stock. Here’s what he said about it on the 25th of April:

“Now we’ve got some healthcare, some issues to talk about on Thursday, that’s right, and these are anything but common, steady healthcare companies. We’ve got Eli Lilly that’s riding the wave of GLP-1 success…. Lilly’s last report laid an egg. They did it right on our show, unfortunately. I’m counting on this one being better, which is why we continue to own it for the Charitable Trust.”

Page 11 of 12